Deciphering the Genetic Architecture of Autoimmune Diseases
Launched by NATIONAL HUMAN GENOME RESEARCH INSTITUTE (NHGRI) · Apr 28, 2025
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the genetic factors that may lead to autoimmune diseases in people native to Peru. Autoimmune diseases occur when the body's immune system mistakenly attacks its own cells, and these can be influenced by the genes we inherit. While much is known about these diseases in people from Europe and Asia, researchers want to learn more about how they affect individuals from North and South America, as the disease patterns may be different.
To participate in this study, you need to be 18 years or older and have been diagnosed with an autoimmune disease, such as lupus, rheumatoid arthritis, or scleroderma. Family members of those with these diseases and healthy volunteers from the same community are also welcome. Participants will attend two clinic visits two weeks apart, where they will undergo a physical exam, answer health-related questions, and provide blood and urine samples. The study will cover travel costs to the clinics, and participants will receive $30 for each visit along with a snack. This is a great opportunity to help researchers better understand autoimmune diseases and potentially improve treatment options in the future.
Gender
ALL
Eligibility criteria
- * INCLUSION CRITERIA:
- • Any person who meets the criteria for inclusion in the study will be considered and must have the patient's signed informed consent for participation.
- Autoimmune Disease Diagnosis:
- Cases:
- • Patients diagnosed with SLE, Sjogren's disease, scleroderma, rheumatoid arthritis, seronegative spondyloarthropathies, and systemic vasculitis, as defined by the American College of Rheumatology classification criteria.
- • Over 18 years old
- Controls:
- • Family members of identified cases, and unrelated individuals. The controls would be from the same community as the patients and families studied, and of the same age and gender. Screening for autoimmune diseases and allergic diseases will be performed.
- • Over 18 years old
- EXCLUSION CRITERIA:
- • -People diagnosed with a chronic viral disease: HIV, hepatitis C or HTLV-1.
About National Human Genome Research Institute (Nhgri)
The National Human Genome Research Institute (NHGRI) is a prominent research organization within the National Institutes of Health (NIH) dedicated to advancing the field of genomics and its applications in health and medicine. NHGRI sponsors and conducts a wide range of clinical trials aimed at understanding the genetic basis of diseases, developing innovative genomic technologies, and translating genomic research into clinical practice. With a commitment to ethical research and collaboration, NHGRI plays a pivotal role in shaping the future of personalized medicine and improving patient outcomes through genomic discoveries.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethesda, Maryland, United States
Lima, , Peru
Patients applied
Trial Officials
Cristina M Lanata, M.D.
Principal Investigator
National Human Genome Research Institute (NHGRI)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported